Vertex Pharmaceuticals (VRTX) Profit Margin History

Historical gross, operating and net quarterly profit margin for Vertex Pharmaceuticals (VRTX) over the last 10 years. The current net profit margin for Vertex Pharmaceuticals as of May 25, 2018 is 9.36%.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $40.136B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.